Ngl Fine Chem Ltd vs Vaishali Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of NGL Fine Chem Ltd is ₹ 3063 as of 12 Jun 15:30 . The P/E Ratio of NGL Fine Chem Ltd changed from 16.7 on March 2021 to 32.6 on March 2025 . This represents a CAGR of 14.31% over 5 yearsThe P/E Ratio of Vaishali Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of NGL Fine Chem Ltd changed from ₹ 947.42 crore on March 2021 to ₹ 688.7 crore on March 2025 . This represents a CAGR of -6.18% over 5 yearsThe Market Cap of Vaishali Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of NGL Fine Chem Ltd for the Mar '26 is ₹ 151.69 crore as compare to the Dec '25 revenue of ₹ 132.12 crore. This represent the growth of 14.81% The revenue of Vaishali Pharma Ltd for the Mar '26 is ₹ 28.19 crore as compare to the Dec '25 revenue of ₹ 25.54 crore. This represent the growth of 10.38% The ebitda of NGL Fine Chem Ltd for the Mar '26 is ₹ 23.87 crore as compare to the Dec '25 ebitda of ₹ 26.93 crore. This represent the decline of -11.36% The ebitda of Vaishali Pharma Ltd for the Mar '26 is ₹ 1.06 crore as compare to the Dec '25 ebitda of ₹ 2.45 crore. This represent the decline of -56.73% The net profit of NGL Fine Chem Ltd changed from ₹ 9.22 crore to ₹ 13.49 crore over 8 quarters. This represents a CAGR of 20.96% The net profit of Vaishali Pharma Ltd changed from ₹ 1.28 crore to ₹ 0.29 crore over 4 quarters. This represents a CAGR of -77.34% The Dividend Payout of NGL Fine Chem Ltd changed from 1.95 % on March 2021 to 5.97 % on March 2025 . This represents a CAGR of 25.08% over 5 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About NGL Fine Chem Ltd

NGL Fine-Chem Limited was incorporated on December 18, 1981 as a Private Limited Company in the State of Maharashtra.
The Company became a Public Limited Company.
The Company has got its registered office and factory at New Bombay.
It was promoted by Mr. A.G.Lawande, Mr.R. J. Nachane joined Mr.A.G.Lawande for actively participating in the Management of the Company in 1989.
The Company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

FAQs for the comparison of NGL Fine Chem Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, NGL Fine Chem Ltd or Vaishali Pharma Ltd?

Market cap of NGL Fine Chem Ltd is 1,893 Cr while Market cap of Vaishali Pharma Ltd is 93 Cr

What are the key factors driving the stock performance of NGL Fine Chem Ltd and Vaishali Pharma Ltd?

The stock performance of NGL Fine Chem Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for NGL Fine Chem Ltd and Vaishali Pharma Ltd?

As of June 14, 2026, the NGL Fine Chem Ltd stock price is INR ₹3063.6. On the other hand, Vaishali Pharma Ltd stock price is INR ₹7.14.

How do dividend payouts of NGL Fine Chem Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of NGL Fine Chem Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.